Reply To: Traders Market Weekly: Doing OK After September Gloom, Shutdowns, Strikes & Rates?

26 Sep '23 at 8:52 am #65956
Truman
Participant

Immunovant (IMVT 33.90, +13.47, +66.5%): and Roivant (ROIV) announces positive initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results